News
New Malnutrition Quality Measures Will Lead to Higher Quality, Lower-Cost Care
New quality measures to address malnutrition among hospitalized older adults are now being evaluated by the National Quality Forum (NQF) for endorsement, and by the Centers for Medicare & Medicaid Services (CMS) for inclusion in their Hospital Inpatient Quality Reporting Program.
What are the ACA Enrollment Figures for 2016?
Recently, Avalere worked with the Council for Affordable Health Coverage to examine enrollment trends for the Affordable Care Act (ACA).
Experts Predict Sharp Decline in Competition across the ACA Exchanges
Avalere experts predict that one-third of the country will have no exchange plan competition in 2017, leaving consumers with few options for coverage.
Announcing the Avalere/FasterCures Patient-Perspective Value Framework (PPVF) Initiative and the Steering Committee Members
In June 2016, in collaboration with FasterCures, Avalere launched the Patient-Perspective Value Framework (PPVF) Initiative to develop a value framework that appropriately incorporates the patient's perspective on value.
FDA Has Received $7.67 Billion from Manufactures to Fund Drug Review
Since 1992, the Food and Drug Administration (FDA) has collected $7.67 billion in user fees from pharmaceutical manufacturers to fund drug reviews based on an Avalere analysis of FDA data.
New Cardiac Bundles Could Produce Some Big Winners and Losers
Avalere experts say that the impact for most hospitals will be modest.
Katherine Steinberg, MPP, MBA Joins the Avalere Center for Payment and Delivery Innovation™
Katherine Steinberg comes to Avalere Health with more than 15 years’ experience in the healthcare arena.
Outpatient Services Are the Largest Driver of 2017 Premium Increases
Prescription drugs are not outsized contributors to rate increases.
Most Health Plans Do Not Use Existing Value Frameworks to Make Coverage Decisions
The plans are waiting to see how frameworks will evolve and if physicians embrace them before relying on them to decide which prescription drugs to cover.
Leading Stakeholders Identify Need for Tools to Manage Post-Acute Network Quality
Data show gaps in care integration across provider settings following hospital discharges.
UPDATE: Early Analysis Finds 2017 Proposed Exchange Premiums for Low Cost Silver Plans Increasing 8 Percent on Average
Rates vary widely by state; popular low cost options see smaller increases.
Avalere Welcomes Senior Healthcare Advisor
Wendy Everett, ScD, joins Avalere as a senior advisor.
Providers Across the US Express Interest in Moving to New Cancer Payment Model to Control Medicare Costs
Earlier today, the Centers for Medicare and Medicaid Services (CMS) released participation information for its new Oncology Care Model (OCM) slated to begin July 1.
Health Plans Are Interested in Tying Drug Payments to Patient Outcomes
Hepatitis C and Oncology Are Top Therapeutic Area Targets
MedPAC Proposes Changes for 42 Million Medicare Beneficiaries Enrolled in Part D
Cost-sharing changes could increase costs for many beneficiaries.
13 Million Adults Could Be Eligible to Purchase Medicare Coverage Under Proposed Clinton Plan
A new Avalere analysis finds that nearly 13 million Americans age 50 or over who are currently uninsured or have individual coverage purchased through the private market-inside and outside the exchange- could be eligible to buy-in to the Medicare program under a plan proposed by Democratic presidential candidate Hillary Clinton.
Inovalon Announces Agreement with Bristol-Myers Squibb to Focus on Real World Outcomes & Value-Based Contracting Initiatives
Avalere and Inovalon recently entered into an agreement with Bristol-Meyers Squibb (BMS) to support the manufacturer's innovative initiatives using real-world outcomes data to design and test value-based contracting models. The agreement brings together Avalere's deep expertise on manufacturer and payer contract negotiation and Inovalon's significant data assets to meet the complex challenges around ensuring value and access while addressing growing healthcare costs concerns.
Christie Teigland Receives AMCP Platinum Award
Christie Teigland, PhD, vice president, Advanced Analytics, recently received the Academy of Managed Care Pharmacy’s (AMCP) prestigious Platinum Award for her research entitled “Association of Socioeconomic and Clinical Factors with Rates of High-Risk Medication Use in Medicare Advantage Plans.”
Medicare Beneficiaries Will Pay More for Biosimilars than for Their Biologic Reference Products in Part D
Two Potential Policy Changes Would Reduce Out-of-Pocket Costs for Consumers
Proposed Medicare Part B Rule Would Reduce Payments to Hospitals and Some Specialists, While Increasing Payments to Primary Care Providers
Rule Would Decrease Medicare Reimbursement for Drugs That Cost More than $480 per Day; Seven of the 10 Most Affected Drugs Treat Cancer